BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24484721)

  • 1. Tolerance and benefits of treatment for elderly patients with limited small-cell lung cancer.
    Janssen-Heijnen ML; Maas HA; Koning CC; van der Bruggen-Bogaarts BA; Groen HJ; Wymenga AN
    J Geriatr Oncol; 2014 Jan; 5(1):71-7. PubMed ID: 24484721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
    Li J; Chen P; Dai CH; Li XQ; Bao QL
    Geriatr Gerontol Int; 2009 Jun; 9(2):172-82. PubMed ID: 19740361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
    Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Ohe Y; Nishiwaki Y
    J Thorac Oncol; 2011 Apr; 6(4):796-800. PubMed ID: 21258253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?
    Janssen-Heijnen MLG; Maas HAAM; van de Schans SAM; Coebergh JWW; Groen HJM
    Ann Oncol; 2011 Apr; 22(4):821-826. PubMed ID: 20929965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-cell Lung Cancer in Very Elderly (≥ 80 Years) Patients.
    Schild SE; Zhao L; Wampfler JA; Daniels TB; Sio T; Ross HJ; Paripati H; Marks RS; Yi J; Liu H; He Y; Yang P
    Clin Lung Cancer; 2019 Jul; 20(4):313-321. PubMed ID: 31155475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8(high)CD57(+) T-cell population as an independent predictor of response to chemoradiation therapy in extensive-stage small cell lung cancer.
    Dobrovolskienė NT; Cicėnas S; Kazlauskaitė N; Mišeikytė-Kaubrienė E; Krasko JA; Ostapenko V; Pašukonienė V; Strioga MM
    Lung Cancer; 2015 Nov; 90(2):326-33. PubMed ID: 26319316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
    Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH
    J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients.
    Fiegl M; Pircher A; Waldthaler C; Gamerith G; Kocher F; Pall G; Nevinny M; Schmid T; Sterlacci W; Jamnig H; Zangerl G; Zabernigg A; Oberaigner W; Hilbe W
    Lung Cancer; 2014 May; 84(2):168-74. PubMed ID: 24646832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
    Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
    Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
    Davidoff AJ; Gardner JF; Seal B; Edelman MJ
    J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
    Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
    Pless M; Stupp R; Ris HB; Stahel RA; Weder W; Thierstein S; Gerard MA; Xyrafas A; Früh M; Cathomas R; Zippelius A; Roth A; Bijelovic M; Ochsenbein A; Meier UR; Mamot C; Rauch D; Gautschi O; Betticher DC; Mirimanoff RO; Peters S;
    Lancet; 2015 Sep; 386(9998):1049-56. PubMed ID: 26275735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in study on the therapy for limited-stage small cell lung cancer].
    Zhang H; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):857-62. PubMed ID: 23982001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion.
    Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Saijo N; Nishiwaki Y
    J Thorac Oncol; 2008 Jul; 3(7):723-7. PubMed ID: 18594317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older.
    Shimizu T; Sekine I; Sumi M; Ito Y; Yamada K; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2007 Mar; 37(3):181-5. PubMed ID: 17426103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group.
    Mountzios G; Emmanouilidis C; Vardakis N; Kontopodis E; Hatzidaki D; Popis E; Karachaliou N; Kotsakis A; Agelidou M; Georgoulias V
    Lung Cancer; 2012 Jul; 77(1):146-50. PubMed ID: 22418242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-cell lung cancer: prognostic factors and changing treatment over 15 years.
    Gaspar LE; McNamara EJ; Gay EG; Putnam JB; Crawford J; Herbst RS; Bonner JA
    Clin Lung Cancer; 2012 Mar; 13(2):115-22. PubMed ID: 22000695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-line chemotherapy in small-cell lung cancer: an international analysis.
    Simos D; Sajjady G; Sergi M; Liew MS; Califano R; Ho C; Leighl N; White S; Summers Y; Petrcich W; Wheatley-Price P
    Clin Lung Cancer; 2014 Mar; 15(2):110-8. PubMed ID: 24365050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, Canada.
    Cuffe S; Booth CM; Peng Y; Darling GE; Li G; Kong W; Mackillop WJ; Shepherd FA
    J Clin Oncol; 2012 May; 30(15):1813-21. PubMed ID: 22529258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.